Mary L. Anderson has been appointed vice president of business development, Xoma Ltd. Ms. Anderson will oversee Xoma’s licensing activities related to the company’s therapeutic pipeline, support the antibody collaborations business and the licensing of the company’s antibody technologies, as well as the advancement of biodefense programs.     “For over a decade, Mary has successfully driven multiple product and licensing deals from initiation through negotiation and co...